[go: up one dir, main page]

AR005866A1 - Composicion farmaceutica antioxidante - Google Patents

Composicion farmaceutica antioxidante

Info

Publication number
AR005866A1
AR005866A1 ARP960105366A ARP960105366A AR005866A1 AR 005866 A1 AR005866 A1 AR 005866A1 AR P960105366 A ARP960105366 A AR P960105366A AR P960105366 A ARP960105366 A AR P960105366A AR 005866 A1 AR005866 A1 AR 005866A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
antioxidant pharmaceutical
antioxidant
dehydroestrone
composition
Prior art date
Application number
ARP960105366A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR005866A1 publication Critical patent/AR005866A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)

Abstract

Una composición farmacéutica antioxidante que comprende 8,9-dehidroestrona o una sal farmacéuticamente aceptable del éster 8,9-dehidroestrona-3-sulfatoy un portador farmacéutico. Dicha composición es útil para tratar o inhibir enfermedadesinduc idas por radicales libres.
ARP960105366A 1995-12-04 1996-11-27 Composicion farmaceutica antioxidante AR005866A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US793195P 1995-12-04 1995-12-04

Publications (1)

Publication Number Publication Date
AR005866A1 true AR005866A1 (es) 1999-07-21

Family

ID=21728885

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP960105366A AR005866A1 (es) 1995-12-04 1996-11-27 Composicion farmaceutica antioxidante
ARP070101105A AR059965A2 (es) 1995-12-04 2007-03-19 Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP070101105A AR059965A2 (es) 1995-12-04 2007-03-19 Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante

Country Status (22)

Country Link
EP (1) EP0778025B1 (es)
JP (1) JPH09169650A (es)
KR (1) KR100444002B1 (es)
CN (1) CN1104900C (es)
AR (2) AR005866A1 (es)
AT (1) ATE263565T1 (es)
AU (1) AU703814B2 (es)
BR (1) BR9605777A (es)
CA (1) CA2191835A1 (es)
CZ (1) CZ289780B6 (es)
DE (1) DE69632117T2 (es)
DK (1) DK0778025T3 (es)
ES (1) ES2215187T3 (es)
HU (1) HUP9603329A3 (es)
IL (1) IL119744A (es)
MX (1) MX9606009A (es)
NO (1) NO312654B1 (es)
NZ (1) NZ299858A (es)
PT (1) PT778025E (es)
SI (1) SI0778025T1 (es)
SK (1) SK154296A3 (es)
ZA (1) ZA969923B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
JP2002322081A (ja) * 2001-02-22 2002-11-08 Nonogawa Shoji Kk 生体の遺伝子損傷抑制剤
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
EP1631314B1 (en) * 2003-06-09 2011-08-03 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
US7892751B2 (en) 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene

Also Published As

Publication number Publication date
HK1010095A1 (en) 1999-06-11
SI0778025T1 (en) 2004-08-31
HUP9603329A3 (en) 1998-01-28
DK0778025T3 (da) 2004-06-07
CZ353296A3 (en) 1997-08-13
CZ289780B6 (cs) 2002-04-17
SK154296A3 (en) 1997-08-06
AU703814B2 (en) 1999-04-01
NO965165L (no) 1997-06-05
CA2191835A1 (en) 1997-06-05
BR9605777A (pt) 1998-08-25
EP0778025B1 (en) 2004-04-07
MX9606009A (es) 1997-08-30
EP0778025A1 (en) 1997-06-11
CN1104900C (zh) 2003-04-09
HUP9603329A2 (en) 1997-08-28
DE69632117T2 (de) 2004-08-26
NO965165D0 (no) 1996-12-03
HU9603329D0 (en) 1997-01-28
ATE263565T1 (de) 2004-04-15
ES2215187T3 (es) 2004-10-01
KR100444002B1 (ko) 2004-11-03
AU7194496A (en) 1997-06-12
IL119744A (en) 2003-01-12
IL119744A0 (en) 1997-03-18
JPH09169650A (ja) 1997-06-30
PT778025E (pt) 2004-08-31
KR970032870A (ko) 1997-07-22
ZA969923B (en) 1998-05-26
AR059965A2 (es) 2008-05-14
DE69632117D1 (de) 2004-05-13
NZ299858A (en) 2001-03-30
CN1158725A (zh) 1997-09-10
NO312654B1 (no) 2002-06-17

Similar Documents

Publication Publication Date Title
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
BR9811099A (pt) Inibidores de urocinase
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
EP0699439A3 (en) Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
AR005866A1 (es) Composicion farmaceutica antioxidante
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Legal Events

Date Code Title Description
FC Refusal